Lymphocytic Vasculopathy With Cytoplasmic Antineutrophil Cytoplasmic Antibody Positivity After Upper Respiratory Infection: A Case Report. [PDF]
Jones CL, Sandefur C.
europepmc +1 more source
Sweet-like syndrome secondary to chimeric antigen receptor T-cell therapy for multiple myeloma: a case report. [PDF]
Ouyang X +5 more
europepmc +1 more source
Cutaneous Adverse Effects in Patients Treated with BTK Inhibitors. [PDF]
Robak E, Robak T.
europepmc +1 more source
Progressive Purpura in Microscopic Polyangiitis: A Case Report. [PDF]
Watanabe H +4 more
europepmc +1 more source
Pembrolizumab and Nivolumab-Induced Late Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Case Report. [PDF]
Alqefari A +6 more
europepmc +1 more source
Henoch-Schönlein purpura induced by sitagliptin: A case report. [PDF]
Moschella A, Kirshen C.
europepmc +1 more source
Hydralazine-induced antineutrophil cytoplasmic antibody vasculitis with significant dermatologic manifestations. [PDF]
Patel A +4 more
europepmc +1 more source
Related searches:
Retinal vasculitis associated with cutaneous leukocytoclastic vasculitis
International Ophthalmology, 2017To report a case of retinal vasculitis associated with cutaneous leukocytoclastic vasculitis.Retrospective chart review.A 28-year-old man, who initially presented with occlusive retinal vasculitis and vitreous hemorrhage in right eye that resolved with sectoral photocoagulation.
Soumyava Basu, Ruchi Mittal
openaire +2 more sources
Cutaneous leukocytoclastic vasculitis associated with letrozole
Journal of Oncology Pharmacy Practice, 2013Aromatase inhibitors are increasingly used in the treatment of early and metastatic breast cancer. They can produce various skin adverse effects but are only rarely associated with cutaneous vasculitis. We report the first case of cutaneous vasculitis clearly associated with the use of aromatase inhibitor letrozole.
Digklia A, Tzika E, Voutsadakis IA
openaire +3 more sources
Bullous pemphigoid associated with cutaneous leukocytoclastic vasculitis
International Journal of Dermatology, 1998UK A 79‐year‐old man presented with palpable purpura and poorly defined erythematous plaques on his limbs (Fig. 1). History, examination, and clinical investigations (which included a full blood count, urea, electrolyte, and liver function tests, negative antinuclear and DNA antibodies, antineutrophil cytoplasmic antibody (ANCA), and cold agglutinins ...
Trevor W. Beer, Harvey R. Smith, . Mbbs
openaire +2 more sources

